XML 45 R31.htm IDEA: XBRL DOCUMENT
v3.8.0.1

Investments in and Advances to Unconsolidated Joint Ventures (Tables) | 3 Months Ended
--- | ---
Mar. 31, 2018
Equity Method Investments and Joint Ventures [Abstract] |
Schedule of Equity Method Investments | The Company owns interests in the following entities that are accounted for under the equity method (dollars in thousands):
|  |  |  |  |  | Carrying Amount
|  |  |  |  |  |  |  | March 31, |  | December 31,
Entity(1) |  |  |  | Ownership% |  | 2018 |  | 2017
CCRC JV |  |  |  |  | 49 |  |  | $ | 395,005 |  |  | $ | 400,241 |
RIDEA II(2) |  |  |  |  | 40 |  |  | 328,873 |  |  | 259,651 |
Life Science JVs(3) |  |  |  |  | 50 - 63 |  |  | 65,016 |  |  | 65,581 |
MBK JV |  |  |  |  | 50 |  |  | 37,442 |  |  | 38,005 |
Development JVs(4) |  |  |  |  | 50 - 90 |  |  | 23,733 |  |  | 23,365 |
Medical Office JVs(5) |  |  |  |  | 20 - 67 |  |  | 12,395 |  |  | 12,488 |
K&Y JVs(6) |  |  |  |  | 80 |  |  | 1,298 |  |  | 1,283 |
Advances to unconsolidated joint ventures, net |  |  |  |  |  |  |  | 13 |  |  | 226 |
|  |  |  |  |  |  |  | $ | 863,775 |  |  | $ | 800,840 |
_______________________________________
(1) | These entities are not consolidated because the Company does not control, through voting rights or other means, the JVs.
(2) | Effective January 1, 2018, the Company increased its carrying value in RIDEA II as a net adjustment to retained earnings under its elected transition approach in accordance with the adoption of ASU 2017-05 (see Note 2). See Note 4 for further information on the deconsolidation and pending sale of RIDEA II.
(3) | Includes the following unconsolidated partnerships (and the Company’s ownership percentage): (i) Torrey Pines Science Center, LP (50%); (ii) Britannia Biotech Gateway, LP (55%); and (iii) LASDK, LP (63%).
(4) | Includes four unconsolidated SHOP development partnerships (and the Company’s ownership percentage): (i) Vintage Park Development JV (85%); (ii) Waldwick JV (85%); (iii) Otay Ranch JV (90%); and (iv) MBK Development JV (50%).
(5) | Includes three unconsolidated medical office partnerships (and the Company’s ownership percentage): HCP Ventures IV, LLC (20%); HCP Ventures III, LLC (30%); and Suburban Properties, LLC (67%).
(6) | Includes three unconsolidated JVs.

X
- References No definition available. + Details
Name: | us-gaap_EquityMethodInvestmentsAndJointVenturesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of equity method investments including, but not limited to, name of each investee or group of investments, percentage ownership, difference between recorded amount of an investment and the value of the underlying equity in the net assets, and summarized financial information. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 323 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=66011266&loc=d3e33918-111571 + Details
Name: | us-gaap_EquityMethodInvestmentsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration